Back to resources

Thought Leadership Expertise

Quality

Cell and Gene Collaborative's "New Year's Resolutions"

Brent Morse and Nate Manley on "FDA's Updated Guidance On Human Genome Editing"

Blake Bergam and Sara Mills on FDA's Guidance on Human- and Animal-Derived Materials in CGT

Best practices in preclinical development of cell therapy products

BioTechLogic: the right horse for the right course

Amanda Mack and Alicja Fiedorowicz on FDA's Draft Guidance on Safety Testing of Human Allogeneic Cells

AAVs: the search for actionable advice and/or paths forward

Anthony Davies looks ahead to the rest of 2021

Aducanumab’s approval: what does it mean for cell & gene?